Influenza-COVID Combo Vaccine Trial Halted Over Safety Concerns
The U.S. Food and Drug Administration (FDA) has put a hold on Novavax’s COVID-influenza combination vaccine and standalone influenza vaccines being tested in clinical trials after a participant reported nerve damage following receipt of the experimental vaccine in January 2024.1 Reported symptoms were diagnosed as motor neuropathy, a disease process that can be acquired, hereditary […]
